AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05855317 — intervention group
Intervention type: OTHER
Intervention: Blood sample
Description: Additional blood samples will be taken on a catheter, used for standard care.
Study NCT05178056 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Cord Epidural Stimulation
Description: Spinal Cord Epidural Stimulation (scES) will be administered by a multi-electrode array (5-6-5 SpecifyTM electrode, MEDTRONIC, Minneapolis, MN, USA) previously implanted in the epidural space over the dorsum of the spinal cord.
Study NCT05178056 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spinal Cord Epidural Stimulation
Description: Spinal Cord Epidural Stimulation (scES) will be administered by a multi-electrode array (5-6-5 SpecifyTM electrode, MEDTRONIC, Minneapolis, MN, USA) previously implanted in the epidural space over the dorsum of the spinal cord.
Study NCT05178056 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Training
Description: Standard threshold Positive Expiratory Pressure Device and standard threshold Inspiratory Muscle Trainer (Respironics Inc., Cedar Grove, NJ) assembled together will be used for respiratory training sessions to complete eighty 45-minute sessions during 16 weeks. The participants will be instructed to perform inspiratory and expiratory efforts against a pressure treshold load.
Study NCT05178056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory Training
Description: Standard threshold Positive Expiratory Pressure Device and standard threshold Inspiratory Muscle Trainer (Respironics Inc., Cedar Grove, NJ) assembled together will be used for respiratory training sessions to complete eighty 45-minute sessions during 16 weeks. The participants will be instructed to perform inspiratory and expiratory efforts against a pressure treshold load.
Study NCT05145478 — intervention group
Intervention type: DEVICE
Intervention: Shockwave Intravascular Lithotripsy (IVL)
Description: Eligible patients with atherosclerotic lesions in the femoral artery who either have claudication or critical limb ischemia will receive endovascular treatment in addition to be treated with Shockwave Intravascular Lithotripsy (IVL) technology.
Study NCT05488080 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Department-level audit and feedback and electronic health record-embedded clinical decision support
Description: This intervention will provide clinicians with Equity Report Cards and clinician decision support on mitigating disparities in quality of care.
Study NCT05601024 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laughter Therapy
Description: The first component of intervention is the laughter therapy that is a combination of warm up exercise, deep breathing exercises, childlike playfulness and laughter exercises. Participants will do laughter therapy with whatsapp group call. Each group will consist of at least 5 people. Each session of laughter therapy will be offered one a weekly and 30-40 minutes each time.
Study NCT05583539 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Thromboelastography
Description: Thromboelastography is a viscoelastic test that measures the dynamics of blood clotting on whole blood samples.
Study NCT06338241 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Biphasic bioceramic of tricalcium phosphate and hydroxyapatite with simvastatin
Description: The intervention description for Galibone+ in the study involves the application of this substance to promote bone regeneration following the extraction of impacted mandibular third molars. Galibone is indicated to treat segmental and cavity bone loss, aesthetic repairs and bone augmentations (such as inlay or onlay grafts); to fill dental alveolar bone; for the placement of dental implants; for the stabilization of osteotomies and prostheses in dentistry.
Study NCT06338241 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bovine Hydroxyapatite
Description: The intervention description for Bio-Oss in the study involves the application of this standard material to promote bone regeneration following the extraction of impacted mandibular third molars. Bio-Oss is a commonly used xenograft material known for its osteoconductive properties.
Study NCT05866393 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clean Hands Accessible and Manageable for Patients
Description: Use of a patient-smart hand sanitation dispenser that provides reminders that are non-beeping reminders.
Study NCT06175962 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRAINING AND EXERCISE
Description: Menopause health training will take place in 2 sessions each week and will be completed in 4 sessions. Each session duration is 45 minutes. Baduanjin exercise training will take place in 2 sessions per week, each session lasting 30 minutes. It will be completed in 8 sessions in total. Relaxing music will be played during the Baduanjin exercise and relaxation will be encouraged. During the Baduanjin exercise, proper posture, conscious breathing and focus of the mind will be prioritized. While the movements are being implemented, their symbolic meanings will be explained to the participants. Women will be asked to perform baduanji 3 times a week for 8 weeks.~During this process, reminder messages will be sent to women via WhatsApp.
Study NCT06155071 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometric Training
Description: The group will receive plyometric exercises in a controlled environment. Following Plyometrics would be performed.~1. Plyo Pushup.~2. Chest Pass.~3. Overhead Throw.~4. Squat jump.~5. Plyo Step-up.~6. Cone jumps.~7. Med Ball drop.~8. Kneeling Squat jump.~9. Lateral jump over hurdle.~10. Overhead throw.~11. Under hand throws.~12. Dynamic Rotational Chest pass.~13. Overhead throw with step.
Study NCT05566652 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neural Pressure Support
Description: To evaluate WOB and asynchronies in patients with low respiratory system compliance undergoing either PSV and NPS.
Study NCT05566652 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Neural Pressure Support
Description: To evaluate WOB and asynchronies in patients with low respiratory system compliance undergoing either PSV and NPS.
Study NCT05566652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation
Description: To evaluate WOB and asynchronies in patients with low respiratory system compliance undergoing either PSV and NPS.
Study NCT05566652 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Pressure Support Ventilation
Description: To evaluate WOB and asynchronies in patients with low respiratory system compliance undergoing either PSV and NPS.
Study NCT06388837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Injectable Platelet Rich Fibrin
Description: Patients underwent mandibular symphysis Onlay bone graft mixed with injectable platelet rich fibrin (I-PRF) placement.
Study NCT06351618 — intervention group
Intervention type: OTHER
Intervention: No intervention will be conducted.
Description: No intervention will be conducted.
Study NCT06388837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xenograft
Description: Patients underwent mandibular symphysis Onlay bone graft mixed with Xenograft (InterOss® Anorganic Cancellous Granules).
Study NCT06155071 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Exercises
Description: The group will receive conventional exercises in a controlled environment. Following conventional exercises would be performed.~1. Pushups.~2. Situps.~3. Lunges 4.500m running.~5.Squats
Study NCT05500040 — intervention group
Intervention type: BEHAVIORAL
Intervention: Multimodal Rehabilitation
Description: The rehabilitation measure is based on the biopsychosocial ICF model of the WHO. A multidisciplinary team of therapists looks after the patients during their stay in rehabilitation. Taking into account the physical and psychological condition of the patients, an individual therapy plan is created that is tailored to their needs.
Study NCT05763160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZL-012
Description: Ready to use drug product for injection into the subcutaneous fat
Study NCT06553950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botox injection
Description: Patients will be treated by Botox injection in lateral pterygoid muscle and medications like muscle relaxants, antidepressants and nonsteroidal anti-inflammatory drugs.~A Botox-A vial was diluted with normal saline to a concentration of 10 U per 0.1 mL for injection in a 1-ml insulin syringe. This will be injected into the ipsilateral lateral pterygoid muscle.
Study NCT06553950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mandibular stabilization splint
Description: Patients will be treated by mandibular stabilization splint and medications like muscle relaxants, antidepressants and nonsteroidal anti-inflammatory drugs.
Study NCT06553950 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Muscle relaxant
Description: Patients will be treated by medications like muscle relaxants, antidepressants and nonsteroidal anti-inflammatory drugs.
Study NCT05542888 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sacroiliac joint mobilization
Description: Sacroiliac joint mobilization will be performed with the patient in side lying position in which grade I,II pain relief mobilization will be given in PA direction.It will be given as 1 set of 30 oscillations per session, 3 times per week for 4 weeks.
Study NCT05542888 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard therapy
Description: Postural education, Hot pack, Antenatal exercises
Study NCT05542888 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: Postural education, Hot pack, Antenatal exercises
Study NCT06310096 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TLF fascial stretching exercise
Description: Relaxed lumbo-pelvic upright sitting with arms in neutral anatomical position (O'Sullivan et al., 2006). The subjects had to bend both knee flexed 90. The feet of the Participant lied flat on the ground. Trunk was in aligned position and the angle between upper body and lower body was 90. Seated position led to caudal tensioning of the pTLF via stretching of the gluteus maximus (GM)~Seated position with passive arms elevation Seated position with passive caudal stretching of TLF through thigh elevation. The subjects had to bend both hips while keeping their feet onto a stool (30 cm high) so to pull the GM and the TLF
Study NCT06310096 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy program.
Description: hotpack, ultrasound ,Tens
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SLIMM
Description: Increase in light walking activity, replacing 1 hour/day of sedentary duration with casual walking duration. Increase in sedentary breaks, from sitting/lying position to standing position, at least once every hour as independent of the total time spent on sedentary activities.
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SLIMM
Description: Increase in light walking activity, replacing 1 hour/day of sedentary duration with casual walking duration. Increase in sedentary breaks, from sitting/lying position to standing position, at least once every hour as independent of the total time spent on sedentary activities.
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: SLIMM
Description: Increase in light walking activity, replacing 1 hour/day of sedentary duration with casual walking duration. Increase in sedentary breaks, from sitting/lying position to standing position, at least once every hour as independent of the total time spent on sedentary activities.
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard Resistance Training
Description: Participants will be provided a standard resistance training regimen to follow during the course of the study. Participants will not receive individualized instruction, guidance or modification to the resistance training regimen.
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Guided Resistance Training
Description: Supervised resistance training sessions are individualized for a low-resistance, high-repetition regimen of lower body major muscle groups with established guidelines. Instructions and resistance training bands will be provided for home use. Study participants will record compliance to the resistance training regimen for further guidance and potential modification.
Study NCT05173714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided Resistance Training
Description: Supervised resistance training sessions are individualized for a low-resistance, high-repetition regimen of lower body major muscle groups with established guidelines. Instructions and resistance training bands will be provided for home use. Study participants will record compliance to the resistance training regimen for further guidance and potential modification.
Study NCT05173714 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Oral placebo tablets (matching the experimental semaglutide) will be administered from the first through ninth months of the drug intervention period.
Study NCT05173714 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo tablets (matching the experimental semaglutide) will be administered from the first through ninth months of the drug intervention period.
Study NCT05173714 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Oral semaglutide 3 mg/day will be administered for the first month of study drug intervention period, if tolerated, the dose will increase to 7 mg/day for the second month and to a maximum dose of 14 mg/day from the third through ninth months of the drug intervention period.
Study NCT05747495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online training in CPR-AED
Description: The online training has been designed according to the Catalan Resuscitation Council (CCR) and the European Resuscitation Council (ERC) guidelines. The aim of this training is to provide theoretical and practical knowledge to respond to aid situations (from unconscious people to drowning, both adults and children), as well as the use of the AED.~The contents are available at the link \[https://register.magnore.com/registre-curs-de-reanimacio-cardiopulmonar-dea/\].
Study NCT05686434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: This is a prospective, open, single-center, single-arm phase II clinical study with EGFR-sensitive mutations (Ex19del and L858R) identified in the central laboratory，to evaluate the efficacy and safety of adjuvant Osimertinib therapy in completely resected stage I non-squamous non-small cell lung cancer (NSCLC) with high-risk factors (solid and/or micropapillary component ≥10%, and/or airway spread).
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib 100mg
Description: Patients will begin dabrafenib (150mg PO BID) and trametinib (2mg PO once daily) on day one and will continue for 28 days. After 7 days, nilotinib will be added at 100mg PO BID and will continue for 21 days. For each subsequent cycle, nilotinib will be given for 28 days.
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib 200mg
Description: Patients will begin dabrafenib (150mg PO BID) and trametinib (2mg PO once daily) on day one and will continue for 28 days. After 7 days, nilotinib will be added at 200mg PO BID and will continue for 21 days. For each subsequent cycle, nilotinib will be given for 28 days.
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib 300mg
Description: Patients will begin dabrafenib (150mg PO BID) and trametinib (2mg PO once daily) on day one and will continue for 28 days. After 7 days, nilotinib will be added at 300mg PO BID and will continue for 21 days. For each subsequent cycle, nilotinib will be given for 28 days.
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib 400mg
Description: Patients will begin dabrafenib (150mg PO BID) and trametinib (2mg PO once daily) on day one and will continue for 28 days. After 7 days, nilotinib will be added at 400mg PO BID and will continue for 21 days. For each subsequent cycle, nilotinib will be given for 28 days.
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: All patients will begin dabrafenib (150mg PO BID) on day one and will continue for 28 days.
Study NCT04903119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: All patients will begin trametinib (2mg PO once daily) on day one and will continue for 28 days.
Study NCT05007249 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Use of the Chalaxie pedagogical evaluation tool
Description: Use of the Chalaxie pedagogical evaluation tool during two visits
Study NCT05446025 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: Orexigenic hormones (appetizing) Orexin, galanin and anorexigenic hormones (decreasing appetite) aMSH and CART blood levels will be measured
Study NCT04853524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: JNJ-56136379 tablets will be administered orally.
Study NCT04853524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Description: A combination of BIC, FTC and TAF will be administered orally.
Study NCT05270850 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Conventional treatment for benign airway stenosis Including, but is not limited to laser, high-frequency electric knife, argon plasma coagulation (APC), cryotherapy, balloon dilation, and metal stent placement
Study NCT05270850 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SVF group
Description: SVF treatment following the conventional treatment for benign airway stenosis and respiratory tract fistula
Study NCT06426199 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chitosan-Hyaluronate Gel Mixture
Description: The operation will be under GA. TMJ arthroscopy will performed by the same TMJ arthroscopy surgeon. Lysis and lavage will be performed in the upper joint space in all cases based on the triangulation technique with an inferolateral approach. The arthroscopic procedure will include lysis of adhesions, lavage, manipulation, and debridement of the upper joint space. A 1.9-mm arthroscope with a video monitoring and recording system and a 2.2-mm protective cannula sheath will be used for TMJ arthroscopy. Ringer's lactate will be used as irrigation fluid. Both groups will receive the same arthroscopic treatments. The injection of 2 ml of Chitosan-Hyaluronate Gel Mixture into affected joints will be performed. Needles will be removed after the injection sites and covered its sites with gauze dressing.
Study NCT06426199 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic Acid
Description: The operation will be under GA. TMJ arthroscopy will performed by the same TMJ arthroscopy surgeon. Lysis and lavage will be performed in the upper joint space in all cases based on the triangulation technique with an inferolateral approach. The arthroscopic procedure will include lysis of adhesions, lavage, manipulation, and debridement of the upper joint space. A 1.9-mm arthroscope with a video monitoring and recording system and a 2.2-mm protective cannula sheath will be used for TMJ arthroscopy. Ringer's lactate will be used as irrigation fluid. Both groups will receive the same arthroscopic treatments. The injection of 2 ml of Hyaluronic acid into affected joints will be performed. Needles will be removed after the injection sites and covered its sites with gauze dressing.
Study NCT06166225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-based weight loss program
Description: 12-month, automated and behaviorally-based, Internet-delivered weight loss and weight loss maintenance program
Study NCT06166225 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Internet-based weight loss program
Description: 12-month, automated and behaviorally-based, Internet-delivered weight loss and weight loss maintenance program
Study NCT06166225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: 9-month Iyengar yoga program consisting of live (Zoom) yoga classes delivered 1-2 times per week during months 4-12, and self-guided yoga practice recommendations.
Study NCT06166225 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health and Wellness
Description: 9-month health and wellness program consisting of live (Zoom) yoga classes delivered 1-2 times per week during months 4-12.
Study NCT04369495 — intervention group
Intervention type: OTHER
Intervention: BAFF serum levels
Description: BAFF levels in serum in visit 0,1,2 during induction therapy
Study NCT04654091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoteraphy with liquid nitrogen
Description: Weekly, at each visit, before applying the treatment, a debridement of the hyperkeratotic tissue covering the wart will be performed with a scalpel handle of number 3 and a scalpel blade of number 15, and then the treatment will be applied.~Subsequently, the application of cryotherapy with liquid nitrogen will be carried out using CryoPen b® (HO Equipment, Hhislenghien-Belgium). To analyze the homogeneous application in all the patients in the study, perform 2 applications of 15 seconds per session, with an interval of 30 seconds between each application, such and as manufacturers recommend. The number of sessions in which the product is applied will be a maximum of 5, following the procedure of previous studies.